Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

630 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquired pneumonia: a randomized, open-label, multicenter study of clinical efficacy and tolerability.
Lode H, File TM Jr, Mandell L, Ball P, Pypstra R, Thomas M; 185 Gemifloxacin Study Group. Lode H, et al. Clin Ther. 2002 Nov;24(11):1915-36. doi: 10.1016/s0149-2918(02)80088-1. Clin Ther. 2002. PMID: 12501883 Clinical Trial.
Comparative efficacies and tolerabilities of intravenous azithromycin plus ceftriaxone and intravenous levofloxacin with step-down oral therapy for hospitalized patients with moderate to severe community-acquired pneumonia.
Zervos M, Mandell LA, Vrooman PS, Andrews CP, McIvor A, Abdulla RH, de Caprariis PJ, Knirsch CA, Amsden GW, Niederman MS, Lode H. Zervos M, et al. Among authors: lode h. Treat Respir Med. 2004;3(5):329-36. doi: 10.2165/00151829-200403050-00006. Treat Respir Med. 2004. PMID: 15606222 Clinical Trial.
Double-blind, randomized study of the efficacy and safety of oral pharmacokinetically enhanced amoxicillin-clavulanate (2,000/125 milligrams) versus those of amoxicillin-clavulanate (875/125 milligrams), both given twice daily for 7 days, in treatment of bacterial community-acquired pneumonia in adults.
File TM Jr, Lode H, Kurz H, Kozak R, Xie H, Berkowitz E; 600 Study Group. File TM Jr, et al. Among authors: lode h. Antimicrob Agents Chemother. 2004 Sep;48(9):3323-31. doi: 10.1128/AAC.48.9.3323-3331.2004. Antimicrob Agents Chemother. 2004. PMID: 15328092 Free PMC article. Clinical Trial.
HIV infection does not influence clinical outcomes in hospitalized patients with bacterial community-acquired pneumonia: results from the CAPO international cohort study.
Christensen D, Feldman C, Rossi P, Marrie T, Blasi F, Luna C, Fernandez P, Porras J, Martinez J, Weiss K, Levy G, Lode H, Gross P, File T, Ramirez J; Community-Acquired Pneumonia Organization Investigators. Christensen D, et al. Among authors: lode h. Clin Infect Dis. 2005 Aug 15;41(4):554-6. doi: 10.1086/432063. Epub 2005 Jul 6. Clin Infect Dis. 2005. PMID: 16028168
Gemifloxacin for community-acquired pneumonia.
Lode HM, Schmidt-Ionas M, Stahlmann R. Lode HM, et al. Expert Opin Investig Drugs. 2008 May;17(5):779-86. doi: 10.1517/13543784.17.5.779. Expert Opin Investig Drugs. 2008. PMID: 18447602 Review.
630 results